F M Investments LLC Takes $461,000 Position in Orthofix Medical Inc. (NASDAQ:OFIX)

F M Investments LLC bought a new stake in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 26,400 shares of the medical device company's stock, valued at approximately $461,000. F M Investments LLC owned approximately 0.07% of Orthofix Medical at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the stock. JPMorgan Chase & Co. grew its position in Orthofix Medical by 244.1% during the 4th quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company's stock worth $5,070,000 after acquiring an additional 205,972 shares during the last quarter. Emerald Advisers LLC grew its holdings in shares of Orthofix Medical by 12.2% during the fourth quarter. Emerald Advisers LLC now owns 822,377 shares of the medical device company's stock worth $14,359,000 after purchasing an additional 89,717 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in shares of Orthofix Medical in the fourth quarter valued at approximately $1,286,000. Teacher Retirement System of Texas raised its holdings in Orthofix Medical by 90.0% in the 4th quarter. Teacher Retirement System of Texas now owns 135,009 shares of the medical device company's stock valued at $2,357,000 after buying an additional 63,939 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Orthofix Medical during the 4th quarter worth approximately $1,003,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Orthofix Medical

In related news, insider Lucas Vitale sold 4,287 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total transaction of $71,164.20. Following the transaction, the insider now owns 135,317 shares in the company, valued at $2,246,262.20. The trade was a 3.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last three months, insiders have sold 5,426 shares of company stock valued at $90,919. 2.60% of the stock is currently owned by company insiders.

Orthofix Medical Trading Down 0.0 %

Shares of NASDAQ:OFIX traded down $0.00 during midday trading on Thursday, reaching $12.96. The company's stock had a trading volume of 54,870 shares, compared to its average volume of 259,210. The firm has a 50 day moving average price of $16.45 and a two-hundred day moving average price of $17.18. Orthofix Medical Inc. has a fifty-two week low of $12.08 and a fifty-two week high of $20.73. The firm has a market capitalization of $505.61 million, a price-to-earnings ratio of -4.13 and a beta of 0.99. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39.

Analyst Ratings Changes

Several equities analysts have recently issued reports on OFIX shares. StockNews.com raised shares of Orthofix Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, February 25th. Roth Mkm reaffirmed a "buy" rating and issued a $22.00 price objective on shares of Orthofix Medical in a research note on Wednesday, February 26th. Finally, Canaccord Genuity Group restated a "buy" rating and set a $24.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $23.33.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.